Here are the Top health stories for the day:
ICMR launches national registry of multiple sclerosis and allied demyelinating disorders
The Indian Council of Medical Research (ICMR) has launched a National Registry of Multiple Sclerosis (MS) and Indian Multiple Sclerosis and Allied Demyelinating Disorders Registry and Research Network (IMSRN).
Multiple sclerosis is a neurological disorder typically affecting young individuals between the ages of 20 and 40 years, but may also occur in children and adolescents.Females are affected more by this disease than males.
Conversion Therapy" for LGBTQIA should be considered as ProfessionalMisconduct by doctors
In a major move that might put a stop to the practice of "Conversion Therapy" on LGBTQIA+ community, the Madras High Court has directed the National Medical Commission (NMC) for enlisting it as professional misconduct.
The court issued this direction to NMC as it took note of the submission by the petitioner's counsel, who referred to various suggestions about the conversion practices and the scope of prohibiting such practices. Reference was also made to the Legislation that is available in two other countries in this regard and also to the United Nations report of the Independent Expert on protection against violence and discrimination based on sexual orientation and gender identity.
For more details, check out the full story on the link below:
HC refuses to stop Sun Pharmaceuticals from using word 'Respules'
The Madras High Court has declined to restrain Sun Pharmaceuticals Industries Limited in Nandanam here from using the word 'Respules' in its business operations.
Justice Senthilkumar Ramamoorthy gave an interim ruling to this effect, while disposing of three interlocutory applications arising out of a civil suit from Cipla Limited in Alapakkam here and in Mumbai, recently.
For more details, check out the full story on the link below:
Sun Versus Cipla: Madras HC Refuses To Stop Sun Pharma From Using Word 'Respules'
MTaI urges the Government not to levy TDS on free medical samples to Doctors and Clinicians
The Medical Technology Association of India has asked the government to reconsider TDS provision on free medical samples provided to doctors.
In a statement issued on Monday, the medical device maker's body, which represents leading research-based medical technology companies, noted that taxation on these samples will adversely affect hands-on training for doctors and clinicians and therefore impact patients' access to life-saving and life-enhancing technologies.
For more details, check out the full story on the link below:
Medical Device Makers Seek TDS Exemption On Free Medical Samples Given To Doctors
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.